Guangzheng Eye Hospital Group (002524) Fair Value & Analysis
Industrials · CN · Market cap 1.8B CNY
Fair value as of: Jul 22, 2026
From 16 valuation models · updated 19 days ago
Fair value updated Jul 22, 2026, revised from ¥0.5600 to ¥1.00 (+78.6%) since Jun 25, 2026. Share price +7.1% over the past month.
Below-average quality, and screening another 75% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥1.28). The favourable scenario is already priced in.
- Solid but not exceptional quality (48/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 22, 2026.
How to read this chart
60‑month range ¥2.95 – ¥15.33 · fair‑value band ¥0.8000 – ¥1.28 · the ¥4.05 price screens above the ¥1.00 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 22, 2026.
Analysis
Guangzheng Eye Hospital Group (002524) currently trades at ¥4.05, while our model-based Fair Value estimate is ¥1.00, implying the stock looks roughly 75.3% overvalued today. The Quality Score stands at 48/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Guangzheng Eye Hospital Group generated revenue of 864M CNY at a net margin of -2.8%. Revenue declined 10.1% year over year. It earns a return on equity of -22.5%. Net debt stands at 223M CNY. Fundamentals as of Jul 22, 2026
Our scenario range runs from ¥0.8000 (bear case) to ¥1.28 (bull case); at ¥4.05, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 27% below its 52-week high and 21% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -72% fair-value upside, at -75%, 002524 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: DCF Models (¥1.80) versus Asset-Based (¥0.1200). Highest evidence: Growth DCF (80).
Notify me when 002524 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 22, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 46 · Market factors (momentum, volatility) 40
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Guangzheng Eye Hospital Group Co.,Ltd. provides various ophthalmic medical services in China. It operates through Steel Structure Segment; Energy Segment; and Medical and Health segment. The steel structure segment engaged in steel structure processing and sales and installation business.
Full company description
Guangzheng Eye Hospital Group Co.,Ltd. provides various ophthalmic medical services in China. It operates through Steel Structure Segment; Energy Segment; and Medical and Health segment. The steel structure segment engaged in steel structure processing and sales and installation business. The energy segment involved in gas station leasing, oil and natural gas sales, and home installation business. The medical and health segment provides ophthalmic medical services. it offers diagnosis and treatment of various eye diseases; medical optometry services; invests in, operates, and manages eye hospitals; and provides related services. In addition, it engages in leasing of houses; and property and consulting services. The company was formerly known as Guangzheng Group Co.,Ltd and changed its name to Guangzheng Eye Hospital Group Co.,Ltd. in October 2020. Guangzheng Eye Hospital Group Co.,Ltd. was founded in 2001 and is headquartered in Xinjiang, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Guangzheng Eye Hospital Group reported revenue of ¥885M in FY2025 versus ¥1.0B in FY2021, a compound −4.1%/yr. Reported net income was −¥19.5M in FY2025.
002524 screens 75% overvalued. Compare with Carpenter Technology Corporation →
Peer Group
Metal Fabrication · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Metal Fabrication median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Metal Fabrication stocks, each showing price versus our Fair Value estimate (as of Jul 22, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Carpenter Technology Corporation CRS | $577.10 | $103.31 | -82% |
| ATI Inc ATI | $186.17 | $36.51 | -80% |
| Mueller Industries, Inc MLI | $59.13 | $60.24 | +2% |
| China International Marine Containers (Group) Co 000039 | ¥7.45 | ¥1.15 | -85% |
| JL Mag Rare-Earth Co 300748 | ¥31.69 | ¥8.74 | -72% |
| Western Superconducting Technologies Co 688122 | ¥56.73 | ¥24.43 | -57% |
| Ningbo Zhenyu Technology Co 300953 | ¥131.65 | ¥44.23 | -66% |
| Anhui Yingliu Electromechanical Co 603308 | ¥48.52 | ¥8.07 | -83% |
| Baoding Technology Co 002552 | ¥43.95 | ¥5.44 | -88% |
| Xiamen Voke Mold & Plastic Engineering Co 301196 | ¥110.08 | ¥42.71 | -61% |
Compare Guangzheng Eye Hospital Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Guangzheng Eye Hospital Group (002524) overvalued or undervalued?
What is the fair value of 002524?
What is the quality score of 002524?
What is the revenue of Guangzheng Eye Hospital Group (002524)?
What is the net profit margin of 002524?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Guangzheng Eye Hospital Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.